Statins and Risk of Intracerebral Haemorrhage in a Stroke-Free Population: A Nationwide Danish Propensity Score Matched Cohort Study

Overview

Journal EClinicalMedicine

Specialty General Medicine

Date 2019 Jun 14

PMID 31193616

Citations 15

Authors

Anette Riisgaard Ribe

Claus Hostrup Vestergaard

Mogens Vestergaard

Morten Fenger-Gron

Henrik Schou Pedersen

Lone Winther Lietzen

Peter Krogh Brynningsen

Affiliations

Soon will be listed here.

Abstract

Background: Statins may increase the risk of intracerebral haemorrhage (ICH) in individuals with previous stroke. It remains unclear whether this applies to individuals with no history of stroke. This study is the first to explore the statin-associated risk of ICH in stroke-free individuals while considering the timing of statin initiation.

Methods: We conducted a population-based, propensity score matched cohort study using information from five Danish national registers. We included all stroke-free individuals initiating statins in 2004-2013 and a propensity score matched group of non-users. Adjusted hazard ratios (aHRs) for ICH risk among statin users compared to non-users were calculated as a function of time since statin initiation.

Findings: 519,894 stroke-free individuals initiating statins and their 1:5 matched stroke-free reference subjects were included and followed for up to ten years. During this period, 1409 ICHs occurred in statin users. Statin users had an overall aHR of 0.85 (95% confidence interval: 0.80-0.90) compared to non-users, but this risk was modified by time since statin initiation. Statin users and non-users had similar ICH risk during the first six months after statin initiation. Hereafter, statin users had a 22-35% lower risk throughout the study period.

Interpretation: Statin users had lower ICH risk than non-users from six months after statin initiation. This finding could not be explained by healthy initiator bias or differences between users and non-users in terms of sociodemographic characteristics, comorbidity, or parallel treatment regimens. Our study suggests that statin use in stroke-free populations is associated with reduced ICH risk.

Funding: The Novo Nordisk Foundation.

Citing Articles

Statin therapy in ischemic stroke patients with atrial fibrillation: Efficacy and safety outcomes.

Marvardi M, Paciaroni M, Caso V Eur Stroke J. 2025; 23969873241307520.

PMID: 39781592 PMC: 11713940. DOI: 10.1177/23969873241307520.

Cholesterol metabolism: physiological versus pathological aspects in intracerebral hemorrhage.

Huang R, Pang Q, Zheng L, Lin J, Li H, Wan L Neural Regen Res. 2024; 20(4):1015-1030.

PMID: 38989934 PMC: 11438341. DOI: 10.4103/NRR.NRR-D-23-01462.

A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs.

Ma F, Zeng Z, Chen J, Zhang J Ann Hematol. 2024; 103(7):2511-2521.

PMID: 38630131 DOI: 10.1007/s00277-024-05734-8.

Interpersonal violent injury and subsequent risk of suicide and deliberate self-harm: a register-based national cohort study from Norway, 2010-2018.

Goldman-Mellor S, Qin P EClinicalMedicine. 2024; 68:102442.

PMID: 38333541 PMC: 10850407. DOI: 10.1016/j.eclinm.2024.102442.

Tissue Engineering and Targeted Drug Delivery in Cardiovascular Disease: The Role of Polymer Nanocarrier for Statin Therapy.

Montelione N, Loreni F, Nenna A, Catanese V, Scurto L, Ferrisi C Biomedicines. 2023; 11(3).

PMID: 36979777 PMC: 10045667. DOI: 10.3390/biomedicines11030798.

References

Ribe A, Laursen T, Charles M, Katon W, Fenger-Gron M, Davydow D . Long-term Risk of Dementia in Persons With Schizophrenia: A Danish Population-Based Cohort Study. JAMA Psychiatry. 2015; 72(11):1095-101. DOI: 10.1001/jamapsychiatry.2015.1546. View

Brookhart M, Schneeweiss S, Rothman K, Glynn R, Avorn J, Sturmer T . Variable selection for propensity score models. Am J Epidemiol. 2006; 163(12):1149-56. PMC: 1513192. DOI: 10.1093/aje/kwj149. View

Prior A, Fenger-Gron M, Larsen K, Breinholt Larsen F, Robinson K, Germund Nielsen M . The Association Between Perceived Stress and Mortality Among People With Multimorbidity: A Prospective Population-Based Cohort Study. Am J Epidemiol. 2016; 184(3):199-210. DOI: 10.1093/aje/kwv324. View

Hackam D, Austin P, Huang A, Juurlink D, Mamdani M, Paterson J . Statins and intracerebral hemorrhage: a retrospective cohort study. Arch Neurol. 2011; 69(1):39-45. DOI: 10.1001/archneurol.2011.228. View

OMahony D, OSullivan D, Byrne S, OConnor M, Ryan C, Gallagher P . STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014; 44(2):213-8. PMC: 4339726. DOI: 10.1093/ageing/afu145. View

Heide-Jorgensen U, Adelborg K, Kahlert J, Sorensen H, Pedersen L . Sampling strategies for selecting general population comparison cohorts. Clin Epidemiol. 2018; 10:1325-1337. PMC: 6165733. DOI: 10.2147/CLEP.S164456. View

Amarenco P, Bogousslavsky J, Callahan 3rd A, Goldstein L, Hennerici M, Rudolph A . High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006; 355(6):549-59. DOI: 10.1056/NEJMoa061894. View

Sussman E, Connolly Jr E . Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke. Front Neurol. 2013; 4:69. PMC: 3677128. DOI: 10.3389/fneur.2013.00069. View

Collins R, Armitage J, Parish S, Sleight P, Peto R . Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004; 363(9411):757-67. DOI: 10.1016/S0140-6736(04)15690-0. View

10.

Mors O, Perto G, Mortensen P . The Danish Psychiatric Central Research Register. Scand J Public Health. 2011; 39(7 Suppl):54-7. DOI: 10.1177/1403494810395825. View

11.

Pedersen C . The Danish Civil Registration System. Scand J Public Health. 2011; 39(7 Suppl):22-5. DOI: 10.1177/1403494810387965. View

12.

Lund J, Richardson D, Sturmer T . The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application. Curr Epidemiol Rep. 2016; 2(4):221-228. PMC: 4778958. DOI: 10.1007/s40471-015-0053-5. View

13.

Wallach Kildemoes H, Sorensen H, Hallas J . The Danish National Prescription Registry. Scand J Public Health. 2011; 39(7 Suppl):38-41. DOI: 10.1177/1403494810394717. View

14.

Krarup L, Boysen G, Janjua H, Prescott E, Truelsen T . Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology. 2007; 28(3):150-4. DOI: 10.1159/000102143. View

15.

Hackam D, Woodward M, Newby L, Bhatt D, Shao M, Smith E . Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation. 2011; 124(20):2233-42. DOI: 10.1161/CIRCULATIONAHA.111.055269. View

16.

Baigent C, Blackwell L, Emberson J, Holland L, Reith C, Bhala N . Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010; 376(9753):1670-81. PMC: 2988224. DOI: 10.1016/S0140-6736(10)61350-5. View

17.

Goldstein L, Amarenco P, Szarek M, Callahan 3rd A, Hennerici M, Sillesen H . Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2007; 70(24 Pt 2):2364-70. DOI: 10.1212/01.wnl.0000296277.63350.77. View

18.

Ariesen M, Claus S, Rinkel G, Algra A . Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003; 34(8):2060-5. DOI: 10.1161/01.STR.0000080678.09344.8D. View

19.

Hemphill 3rd J, Greenberg S, Anderson C, Becker K, Bendok B, Cushman M . Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015; 46(7):2032-60. DOI: 10.1161/STR.0000000000000069. View

20.

McKinney J, Kostis W . Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke. 2012; 43(8):2149-56. DOI: 10.1161/STROKEAHA.112.655894. View